EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0846
0.00 (0.00%)
At close: Sep 30, 2025
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $865.48 thousand as of October 3, 2025. Its market cap has decreased by -92.73% in one year.
Market Cap
865.48K
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 865.48K, a decrease of -98.77%. That is a compound annual growth rate of -34.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 865.48K | -11.37% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | 68.63M | 4,887.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 713.40M |
| Glass House Brands | 610.83M |
| Northwest Biotherapeutics | 378.06M |
| CytoDyn | 326.51M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 287.63M |
| Silence Therapeutics | 240.89M |